RESUMO
We report a case of bifacial weakness with paresthesia, a recognized Guillain-Barré syndrome subtype characterized by rapidly progressive facial weakness and paresthesia without ataxia or other cranial neuropathies, which was temporally associated with antecedent coronavirus 2019 (COVID-19). This case highlights a potentially novel but critically important neurologic association of the COVID-19 disease process. Herein, we detail the clinicoradiologic work-up and diagnosis, clinical course, and multidisciplinary medical management of this patient with COVID-19. This case is illustrative of the increasingly recognized but potentially underreported neurologic manifestations of COVID-19, which must be considered and further investigated in this pandemic disease.
Assuntos
Betacoronavirus , Infecções por Coronavirus/complicações , Paralisia Facial/etiologia , Síndrome de Guillain-Barré/complicações , Parestesia/etiologia , Pneumonia Viral/complicações , COVID-19 , Humanos , Masculino , Pandemias , SARS-CoV-2 , Adulto JovemRESUMO
Composition C-4 (C-4) is a plastic explosive widely used in both military and civilian settings. Ingestion of the active ingredient, RDX (cyclonite), can cause generalized seizures. Accidental and intentional C-4 (RDX) intoxications have occurred during manufacture or in wartime. In the literature the intentional ingestion of C-4 has been reported but not verified. We present a case of intentional C-4 abuse.
